TPG Invests in K2 Medical Research
On June 17 TPG announced that it was making a significant growth investment in K2 Medical Research. K2 Medical Research is a leading clinical research organization (CRO) dedicated to advancing medical science through the efficient and ethical conduct of clinical trials. Its integrated clinical trial site platform specializes in central nervous system trials for leading pharma and biotech sponsor and is focused around complex therapeutic areas including Alzheimer’s, psychiatry and liver disease. The company is based in Florida and operates seven locations across the state. TPG is a global alternative asset management firm with $137 billion of assets under management and... Read More »
Blue Arch Capital Acquires Medical Outpatient Building for $15.25 Million
Avison Young, a global real estate broker, announced on June 17 that Blue Arch Capital acquired a medical outpatient building (MOB) in Silver Spring, Maryland for $15.25 million. Doctors Medical Park consists of three buildings and totals approximately 98,000 square feet. It is spread over 4.8 acres of land and is situated about a mile north of Holy Cross Hospital. The complex’s current tenants include Community Radiology Associates, Fresenius, Capital Women’s Care and The Ladas Eye Group. The price is roughly $156 per-square-foot. Blue Arch Capital is a real estate private equity firm that acquires and operates core-plus and value-add properties in the United States. It is... Read More »
Siegfried Acquires Curia Global’s Early-Phase Manufacturing Site
Siegfried announced on June 13 that it was expanding its global contract development management organization (CDMO) abilities with the acquisition of an early-phase manufacturing site in Grafton, Wisconsin from Curia Global. The Wisconsin facility specializes in early-phase development and manufacturing services and employs more than 80 workers. Siegfried develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. It is based in Zofingen, Switzerland. Curia Global is a... Read More »
PE Firm Great Point Partners Acquires Germany-Based CDMO
Great Point Partners (GPP) announced on June 13 the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany. Founded in 2007, Lyocontract operates from a state-of-the-art pharmaceutical manufacturing facility providing aseptic liquid filling, lyophilization and packaging services. Compliant with the European Union’s Annex 1 standards, the CDMO specializes in the production of liquid and freeze-dried parenteral drugs, distributing globally for both clinical and commercial use. Founded in 2003 and based in Greenwich, Connecticut, GPP is a healthcare investment firm that has provided growth... Read More »
